DOI: 10.1093/infdis/jiae099 ISSN: 0022-1899

Escape Velocity – The Launch of Microbiome Therapies

Brendan J Kelly, Jennie H Kwon, Michael H Woodworth
  • Infectious Diseases
  • Immunology and Allergy

FDA approval of the first microbiota therapeutics raises new questions about the future role of fecal microbiota transplantation (FMT). The authors explore these questions and suggest that FMT has unique value for research and to support patient access.

More from our Archive